Coverage / AMGN / Trade Card

AMGN

Amgen Inc

OPPORTUNISTIC BUY 2026-08-08 Data 35 days old USD 410.95 Healthcare - Drug Manufacturers - GeneralREDUCE ZONE
ACTIONABLEMethodology gates passed
57

Position levels

Currenttoday
USD 410.95
Buy <=wait / entry
USD 333.33
Trim >=take some off
USD 400.00
Thesis breakA negative Phase III readout for MariTide, formal disclosure of an accelerated b...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case23%100 / 10023.0
Base case50%62 / 10031.0
Bear case27%10 / 1002.7
Weighted conviction57 / 100 - OPPORTUNISTIC BUY

Top risks

  • Completed acquisition of Horizon Therapeutics for $27.8 billion equity value
  • Q1 2026 total revenues +6% to $8.6B with 16 brands delivering double-digit sales growth and 17 products annualizing above $1B
  • Product sales +4% driven by 9% volume growth and GAAP EPS +4% to $3.34
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.